A phase Ia study to estimate the radiochemical and radiation safety of 68G a-NYM005, a radiolabeled carbonic anhydrase IX PET imaging agent for diagnosing, staging, and following patients with clear cell renal cell carcinoma.
Year: 2025
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: Peng Fang, Kequan Lou, Waisi Eng, P. David Mozley, Si Yang, Jialiang Wang, Chunjing Yu
Institution: Wuxi Fourth People's Hospital
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410816737